carboxyamidotriazole
Sponsors
National Cancer Institute (NCI), Eastern Cooperative Oncology Group, National Institutes of Health Clinical Center (CC)
Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaBrain and Central Nervous System TumorsBreast CancerFallopian Tube CancerKidney CancerLung Cancer
Phase 1
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
CompletedNCT00019019
Start: 1994-10-31End: 2006-07-31Target: 70Updated: 2012-03-15
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
CompletedNCT00003249
Start: 1998-05-31Updated: 2013-02-07
Phase 2
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
CompletedNCT00019461
Start: 1998-04-30End: 2007-10-31Updated: 2013-06-20
Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
CompletedNCT00006486
Start: 2000-10-31Updated: 2013-01-16
Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
CompletedNCT00004146
Start: 2000-03-31End: 2010-01-31Updated: 2015-05-08
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
CompletedNCT00005045
Start: 2000-03-31End: 2004-06-30Updated: 2013-06-21